On October 26, 2017 Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, reported that it will announce financial results for the third quarter ended September 30, 2017 on November 2, 2017 before the NASDAQ market open (Press release, Loxo Oncology, OCT 26, 2017, https://ir.loxooncology.com/press-releases/loxo-oncology-to-announce-third-quarter-2017-financial-results-and-host-conference-call [SID1234521181]). At 8:00 a.m. ET that day, Loxo Oncology management will host a conference call to discuss these financial results, in addition to recent updates on development and corporate activities.

To participate in the conference call, please dial (877) 930-8065 (domestic) or (253) 336-8041 (international) and refer to conference ID 78661148. A replay will be available shortly after the conclusion of the call and archived on the company’s website for 30 days following the call.